These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12466974)

  • 1. Deregulation of cyclin E2 expression and associated kinase activity in primary breast tumors.
    Payton M; Scully S; Chung G; Coats S
    Oncogene; 2002 Dec; 21(55):8529-34. PubMed ID: 12466974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients.
    Sieuwerts AM; Look MP; Meijer-van Gelder ME; Timmermans M; Trapman AM; Garcia RR; Arnold M; Goedheer AJ; de Weerd V; Portengen H; Klijn JG; Foekens JA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3319-28. PubMed ID: 16740753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D2 expression in familial and sporadic breast cancer.
    Fischer H; Chen J; Skoog L; Lindblom A
    Oncol Rep; 2002; 9(6):1157-61. PubMed ID: 12375011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats.
    Weroha SJ; Li SA; Tawfik O; Li JJ
    Carcinogenesis; 2006 Mar; 27(3):491-8. PubMed ID: 16311245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
    Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
    Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
    Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
    Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
    Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin E both regulates and is regulated by calpain 2, a protease associated with metastatic breast cancer phenotype.
    Libertini SJ; Robinson BS; Dhillon NK; Glick D; George M; Dandekar S; Gregg JP; Sawai E; Mudryj M
    Cancer Res; 2005 Dec; 65(23):10700-8. PubMed ID: 16322214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of cell cycle regulatory molecules and evidence for a "cyclin switch" during progression of prostate cancer.
    Maddison LA; Huss WJ; Barrios RM; Greenberg NM
    Prostate; 2004 Mar; 58(4):335-44. PubMed ID: 14968434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y; Chen S
    Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition.
    Madi L; Ochaion A; Rath-Wolfson L; Bar-Yehuda S; Erlanger A; Ohana G; Harish A; Merimski O; Barer F; Fishman P
    Clin Cancer Res; 2004 Jul; 10(13):4472-9. PubMed ID: 15240539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas.
    Kobatake T; Yano M; Toyooka S; Tsukuda K; Dote H; Kikuchi T; Toyota M; Ouchida M; Aoe M; Date H; Pass HI; Doihara H; Shimizu N
    Oncol Rep; 2004 Nov; 12(5):1087-92. PubMed ID: 15492797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome.
    Bondi J; Husdal A; Bukholm G; Nesland JM; Bakka A; Bukholm IR
    J Clin Pathol; 2005 May; 58(5):509-14. PubMed ID: 15858123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancer.
    Spruck C; Sun D; Fiegl H; Marth C; Mueller-Holzner E; Goebel G; Widschwendter M; Reed SI
    Cancer Res; 2006 Jul; 66(14):7355-60. PubMed ID: 16849587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
    Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
    Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of cyclin D1 and cyclin E in 1,2-dimethylhydrazine dihydrochloride-induced rat colon carcinogenesis.
    Hur K; Kim JR; Yoon BI; Lee JK; Choi JH; Oh GT; Kim DY
    J Vet Sci; 2000 Dec; 1(2):121-6. PubMed ID: 14614307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancer.
    Irahara N; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
    Cancer Lett; 2006 Nov; 243(1):23-31. PubMed ID: 16556483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.